← Eichor
Study identifier: NCT06294600 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Clarithromycin Treatment to Prevent Sepsis Progression in CAP (REACT)

Condition: Community-acquired Pneumonia  ·  Sponsor: Hellenic Institute for the Study of Sepsis

PhasePhase 3
Planned participants330
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The primary objective of the REACT randomized clinical trial (RCT) is to optimize the clinical benefit from adjunctive clarithromycin treatment shown in the ACCESS trial and to provide evidence for the clinical benefit of early start of adjunctive oral clarithromycin guided by suPAR to prevent the progression into sepsis in patients with community-acquired pneumonia (CAP) at risk. This can be achieved by endpoints incorporating clinical benefit with the effect of treatment on the improvement of the immune dysregulation of CAP. The secondary objectives of REACT are to investigate the impact of early adjunctive treatment with clarithromycin on the resolution of CAP at the test-of-cure (TOC) visit.

This description comes directly from the study's public registry record.

Talk to the study team

Evangelos J Giamarellos-Bourboulis, MD, Phd  ·  2105831994  ·  egiamarel@med.uoa.gr

Athanasia Chatzianastasiou, Phd  ·  6938262747  ·  n.chatzianastasiou@sepsis.gr

Always discuss trial participation with your own doctor first.

Locations (24)

5th Pulmonary Department, SOTIRIA Athens General Hospital of Chest DiseasesAthens, Athens, GreeceRecruiting
1st Department of Internal Medicine - General Hospital of Athens "Sismanogleio-Amalia Fleming"Athens, Greece, GreeceNot Yet Recruiting
1st Department of Internal Medicine, AHEPA University General Hospital of ThessalonikiAthens, Greece, GreeceRecruiting
1st Department of Internal Medicine, EVANGELISMOS Athens General HospitalAthens, Greece, GreeceRecruiting
1st Department of Internal Medicine, G. GENNIMATAS Athens General HospitalAthens, Greece, GreeceRecruiting
1st Department of Internal Medicine, General University Hospital of IoanninaAthens, Greece, GreeceRecruiting
1st Department of Internal Medicine, KORGIALENEIO-BENAKEIO E.E.S. Athens General HospitalAthens, Greece, GreeceRecruiting
1st Department of Internal Medicine, THRIASIO General Hospital of ElefsisAthens, Greece, GreeceRecruiting
1st University Department of Pulmonary Medicine, SOTIRIA General Hospital of Chest Diseases of AthensAthens, Greece, GreeceRecruiting
2nd Department of Internal Medicine, Attikon University HospitalAthens, Greece, GreeceRecruiting
2nd Department of Internal Medicine, THRIASIO General Hospital of ElefsisAthens, Greece, GreeceRecruiting
2nd Department of Internal Medicine, TZANEIO Piraeus General HospitalAthens, Greece, GreeceRecruiting

+ 12 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06294600